5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
US7507720B2 · kind B2 · utility
0Cited by
43References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2006 |
| Grant date | Mar 24, 2009 |
| Priority date | — |
| Expiry date | Aug 11, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/0005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention discloses the use of sapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.